Atjaunināt sīkdatņu piekrišanu

E-grāmata: Essentials of Internal Medicine - eBook

, (FRACP, DDU, FCSANZ Cardiologist, Canberra Hospital, Can), (AC, MD, PhD, FRACP, FAFPHM, FRCP (Lond.), FRCP (Edin.), FACP, FAHMS Laureate Professor, University of Newcastle and Senior Staff Specialist, John Hunter Hospital, NSW, Australia)
  • Formāts: PDF+DRM
  • Izdošanas datums: 01-Feb-2020
  • Izdevniecība: Elsevier Australia
  • Valoda: eng
  • ISBN-13: 9780729587440
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 51,33 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: PDF+DRM
  • Izdošanas datums: 01-Feb-2020
  • Izdevniecība: Elsevier Australia
  • Valoda: eng
  • ISBN-13: 9780729587440
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Written by Nicholas J Talley, Simon O'Connor and Brad Frankum, this engaging and instructive text provides practical pathways to diagnosis and up-to-date strategies for implementing evidence-based treatments for prevalent conditions.

Learn how to:

  • identify what is clinically important
  • understand and investigate disease
  • create an effective strategy for treatment
  • use technological diagnostic tools.

This new edition of Essentials of Internal Medicine 4e describes established and trusted diagnostic techniques to equip students and trainees with the skills to succeed in their profession. The visually dynamic text offers a framework of knowledge covering core facts and addressing difficult-to-master topics such as:

  • holistic approach to patient treatment
  • the importance of diagnosis
  • the physician's role in public health
  • the physician as scholar.
  • Contributions from expert clinicians leading the advancement of medicine globally
  • Need-to-know 'clinical pearls' throughout each chapter
  • Memory jog lists and tables
  • Multiple choice questions with end-of-chapter answers and extensive explanations
  • Enhanced eBook version included with purchase
Foreword xix
Preface xx
Acknowledgments xxi
Contributors xxii
The COVID-19 Pandemic xxv
Chapter 1 Internal Medicine In The 21St Century-Best Practice, Best Outcomes
1(4)
Brad Frankum
Simon O'Connor
Nicholas J Taltey
General versus sub-specialty medicine
1(1)
The importance of diagnosis
2(1)
The physician's role in public health
2(1)
The physician as scholar
2(3)
Chapter 2 Evidence-Based Medicine And Critical Appraisal Of The Literature
5(12)
Jane Young
John Attia
Introduction
5(1)
Assessing the evidence
5(3)
Sources of error
5(1)
Assessing potential biases in different study designs
6(2)
Critical appraisal of the literature
8(1)
Interpreting a study's findings
9(1)
Interpreting statistical analysis
10(1)
Interpreting test results
11(2)
Screening
13(1)
Conclusion
13(1)
Acknowledgments
13(1)
Self-assessment questions
14(3)
Chapter 3 Clinical Pharmacology And Toxicology
17(30)
Matt Doogue
Jennifer Martin
Alison Jones
1 Principles Of Clinical Pharmacology
18(1)
Introduction
18(1)
Pharmacokinetics
19(5)
Administration
19(1)
Bioavailability (F)
19(1)
Clearance (CL)
19(2)
Distribution
21(1)
Drug transport
21(1)
Other pharmacokinetics
22(1)
Altered pharmacokinetics
22(1)
Patient size
23(1)
Pharmacodynamics
24(2)
Concentration-response relationships
24(1)
Therapeutic index
24(1)
Drug targets
25(1)
Physiological effects
26(1)
More about the patient
26(1)
The innocent bystander
26(1)
2 Quality Use Of Medicines
26(1)
Getting it right
27(1)
The circle of care
27(1)
Patient profile and drug profile(s)
27(1)
Prescribing
27(1)
The prescribing checklist
28(1)
Deprescribing
28(1)
Adverse drug reactions
28(1)
Drug interactions
29(1)
Types of drug interaction
29(1)
Therapeutic drug monitoring (TDM)
30(1)
Drug regulation
30(1)
Drug research
31(1)
3 Toxicology
32(1)
Epidemiology of poisoning
32(1)
Sources of poisons information and advice
32(1)
Clinical assessment of poisoned patients
32(1)
Investigations
32(1)
Risk assessment
33(1)
Principles of management of poisoned patients
33(1)
Common poisons and their management
34(4)
Acetaminophen (paracetamol)
34(2)
Non-steroidal anti-inflammatory drugs (NSAIDs)
36(1)
Tricyclic antidepressants
36(1)
Newer antidepressants
36(1)
Second generation antipsychotics
37(1)
Benzodiazepines
37(1)
Insulin and oral hypoglycemics
37(1)
Drugs of abuse or misuse
38(1)
Amphetamines
38(1)
Cocaine and crack cocaine
38(1)
Gammahydroxybutyrate (GHB)
38(1)
Opioids, such as heroin, morphine or fentanyl
39(1)
Prescription drug abuse
39(1)
Synthetic cathinones, e.g. `vanilla sky', "ivory wave'
39(1)
Synthetic cannabinoids, e.g. `spice', `K2'
39(1)
Drink spiking
39(1)
Chemicals
39(1)
Acids and alkalis
39(1)
Chlorine
40(1)
Pesticides
40(1)
Lead poisoning
40(1)
Spider bites
40(1)
Snake bites
40(1)
Marine envenomation
41(1)
Terrorism, and use of medical countermeasures
41(3)
Chemical agents
41(1)
Biological agents
41(3)
Self-assessment questions
44(3)
Chapter 4 Genetics
47(16)
John Attia
Tracy Dudding-Byth
Overview
47(1)
The flow of genetic information
48(3)
Transcription
48(1)
Translation
49(1)
Regulation
50(1)
Genetic variation
51(1)
Human disease genes
52(1)
Mendelian diseases
52(1)
Breast cancer predispostion genes
53(1)
Breast and ovarian cancer predisposition genes
53(1)
Calculating the risks of disease
53(2)
Some examples
53(2)
Genetic testing in medicine
55(2)
Cytogenic karyotype
55(1)
Fluorescence in situ hybridization (FISH)
55(1)
Chromosomal microarray (molecular karyotype)
56(1)
Genome-wide association studies
56(1)
Polymerase chain reaction (PCR)
56(1)
Sequencing
56(1)
Mitochondrial DNA
57(1)
Imprinting
57(1)
Common chromosomal genetic conditions
57(1)
Down syndrome
57(1)
Turner syndrome
57(1)
Klinefelter syndrome
57(1)
Acknowledgments
57(1)
Self-assessment questions
58(5)
Chapter 5 Medical Imaging For Internists
63(42)
Lindsay Rowe
1 Chest Radiography
64(1)
Principles of interpretation in chest X-rays
64(8)
Patient demographics
64(1)
Technical assessment
64(2)
Lines, tubes and implants
66(1)
Anatomical review
66(1)
Review areas (`hard to see areas')
67(1)
Summary
67(5)
2 Thoracic Computed Tomography
72(1)
Techniques of examination
72(1)
Principles of interpretation in chest CT
72(5)
Patient demographics
74(1)
Technical review
74(1)
Initial image review
74(1)
Key image review
75(1)
Systematic review
76(1)
Review areas
76(1)
Summary
76(1)
3 Abdominal Computed Tomography
77(1)
Techniques of examination
77(1)
Non-contrast CT abdomen
78(1)
Non-contrast CT KUB
78(1)
Arterial phase CT abdomen (CT angiogram, CTA)
78(1)
Portal venous CT abdomen
78(1)
Triple-phase CT abdomen
78(1)
Delayed CT abdomen
78(1)
Principles of interpretation in abdominal CT
78(4)
Patient demographics
78(1)
Technical review
78(1)
Initial image review
79(1)
Key image review
79(3)
Systematic review
82(1)
Review areas
82(1)
Summary
82(1)
4 Abdominal Ultrasound
82(1)
Background--ultrasound principles
82(1)
Principles of ultrasound interpretation
83(2)
Lower limb duplex ultrasound
85(1)
5 Head Computed Tomography
86(1)
CT brain protocols
86(1)
Non-contrast (NCCT)
86(1)
Contrast-enhanced (CECT)
86(1)
CT angiography (CTA)
86(1)
Perfusion CT
87(1)
Principles of interpretation in brain CT
87(6)
Patient demographics
88(1)
Technical review
88(1)
Initial image review
88(2)
Key image review
90(3)
Systematic review
93(1)
Review areas
93(1)
Summary
93(1)
6 Head Magnetic Resonance
93(1)
MRI protocols
94(5)
T1
94(1)
T2
94(1)
Inversion recovery (IR)
95(1)
Diffusion-weighted imaging (DWI)
95(3)
Gradient echo (GRE)
98(1)
Gadolinium-enhanced (GAD)
98(1)
Magnetic resonance angiography/venography (MRA, MRV)
99(1)
MR spectroscopy (MRS)
99(1)
Magnetic resonance gated intracranial cerebrospinal dynamics (MR-GILD, CSF flow study)
99(1)
Principles of interpretation in brain MR
99(4)
Patient demographics
99(1)
Technical review
99(1)
Initial image review
99(1)
Key image review
100(3)
Systematic review
103(1)
Review areas
103(1)
Summary
103(1)
7 Positron Emission Tomography (PET)
103(2)
Chapter 6 Pulmonology
105(40)
David Arnold
Peter Wark
Michael Hensley
Brad Frankum
Lucy Morgan
1 Pulmonary Medicine
106(1)
Clinical presentations of respiratory disease
106(1)
Important clinical clues
106(4)
Dyspnea
106(1)
Patterns of breathing
107(1)
Chronic cough
108(1)
Clubbing
108(1)
Hemoptysis
108(1)
Solitary pulmonary nodule (coin lesion)
109(1)
Mediastinal masses
109(1)
Wheeze
109(1)
Chest pain
109(1)
Stridor
110(1)
Overview of the respiratory system and pathophysiology
110(2)
Functional anatomy and physiology
110(1)
Hypoxemia
111(1)
Hypercapnia
111(1)
Oxygen-hemoglobin association-dissociation curve
112(1)
Acid-base disturbances from a pulmonary perspective
112(1)
Respiratory acidosis
112(1)
Respiratory alkalosis
112(1)
Measurement of lung function
112(2)
Spirometry
112(2)
Interpretation of lung volumes
114(1)
Diffusing capacity for carbon monoxide (DLCOtest)
114(1)
Flow-volume loops
114(1)
Interpretation of pulmonary function tests
114(1)
Control of breathing
114(1)
Respiratory tract defenses
114(2)
Mechanical defenses
114(1)
Immune system
115(1)
Genetics of lung disease
116(1)
Pulmonary disorders
116(1)
Respiratory failure
116(1)
Hypoventilation
116(1)
Diseases of the airways
116(11)
Asthma
116(2)
Allergic bronchopulmonary aspergillosis (ABPA)
118(1)
Bronchiectasis
118(1)
Cystic fibrosis (CF)
119(1)
Bronchiolitis
119(2)
Chronic obstructive pulmonary disease (COPD)
121(1)
Interstitial lung disease (ILD)
122(2)
Idiopathic pulmonary fibrosis
124(1)
Occupational lung disease
124(2)
Granulomatous ILD
126(1)
Eosinophilic pulmonary disorders
127(1)
Pulmonary hemorrhage
127(1)
Pulmonary infections
127(5)
Bacterial
127(1)
Viral
128(1)
Fungal
128(1)
Mycobacterial
129(1)
Other aspects
130(2)
Pleural disease
132(1)
Pleural effusion
132(1)
Pneumothorax
132(1)
Indications for a chest drain
132(1)
Pulmonary vascular disease
132(2)
Pulmonary hypertension (PH)
132(1)
Pulmonary embolism (PE)
133(1)
Diagnosis
133(1)
Lung transplantation
134(1)
Complications of lung transplantation
134(1)
Respiratory sleep medicine
135(2)
Overview of sleep medicine
135(1)
Important clinical clues
135(1)
Respiratory sleep disorders
135(2)
2 Critical Care Medicine
137(1)
Resuscitation
137(1)
Cardiac arrest (CA)
137(1)
Diagnosis and disease management
137(2)
Shock
137(1)
Acute respiratory distress syndrome (ARDS)
137(2)
Mechanical ventilation of the lungs
139(3)
Non-invasive positive-pressure ventilation (NIV)
140(1)
Invasive positive-pressure ventilation (IPPV)
140(1)
Extracorporeal membrane oxygenation (ECMO)
141(1)
Self-assessment questions
142(3)
Chapter 7 Cardiology
145(66)
Peter Thompson
Clinical evaluation of the patient
146(6)
Taking the history--possible cardiac symptoms
146(2)
Physical examination
148(4)
Investigation of cardiac disease
152(8)
Electrocardiography (EKG)
152(1)
Holter (continuous EKG) monitoring
152(1)
Ambulatory blood pressure monitoring
152(3)
Radionuclide ventriculography
155(1)
Chest X-ray (CXR)
155(1)
Echocardiography
155(3)
Radionuclide myocardial perfusion imaging
158(1)
Coronary angiography and cardiac catheterization
158(1)
Coronary CT angiography (CTCA, CCTA) and calcium scoring
159(1)
Magnetic resonance imaging (MRI)
160(1)
Dyslipidemia
160(4)
Cholesterol, lipoproteins, apoproteins
161(1)
Dyslipidemia and cardiovascular disease (CVD)
162(2)
Lipid-modifying treatments
164(1)
Coronary artery disease (CAD)
164(1)
Prevalence
164(1)
Pathophysiology
164(1)
Stable coronary artery disease
165(4)
Investigation
165(2)
Management to improve prognosis
167(1)
Management of symptoms in the CHD patient
168(1)
Management of refractory angina
169(1)
Acute coronary syndromes
169(5)
Terminology
169(1)
Pathophysiology of acute coronary syndromes
170(2)
Management of STEMI
172(1)
Management of NSTEACS/NSTEMI
173(1)
Pharmacological therapy in acute coronary syndromes
174(1)
Valvular heart disease
174(1)
Mitral valve disease
175(3)
Mitral stenosis (MS)
175(1)
Mitral regurgitation (MR)
176(2)
Mitral valve prolapse (MVP) syndrome
178(1)
Aortic valve disease
178(3)
Aortic stenosis (AS)
178(2)
Aortic regurgitation (AR)
180(1)
Tricuspid valve disease
181(1)
Tricuspid stenosis (TS)
181(1)
Tricuspid regurgitation (TR)
182(1)
Pulmonary valve disease
182(1)
Assessing the severity of valvular heart disease and deciding on surgery
182(1)
Cardiomyopathies
182(5)
Dilated cardiomyopathy (DCM)
182(3)
Hypertrophic cardiomyopathy (HCM)
185(1)
Restrictive cardiomyopathy
186(1)
Other cardiomyopathies
186(1)
Cardiac arrhythmias
187(8)
Sinus node disturbances
187(1)
Sick sinus syndrome
187(1)
Supraventricular premature complexes (ectopics)
188(1)
Supraventricular tachycardia (SVT)
188(1)
Atrial flutter
189(1)
Atrial fibrillation (AF)
190(4)
Ventricular arrhythmias
194(1)
Conduction defects
195(2)
Bundle branch block (BBB)
195(1)
Fascicular blocks (hemibtocks)
196(1)
Atrioventricular (AV) blocks
196(1)
Cardiac failure
197(5)
Definition
197(1)
Causes
197(1)
Diagnosis of congestive heart failure
197(2)
Treatment
199(2)
Devices
201(1)
Infective endocarditis
202(2)
Microbiology
202(1)
Diagnosis
203(1)
Management
203(1)
Prevention
204(1)
Pericardial diseases
204(4)
Acute pericarditis
204(2)
Pericardial effusion and tamponade
206(1)
Chronic pericardial disease
207(1)
Self-assessment questions
208(3)
Chapter 8 Hypertension
211(14)
Annemarie Hennessy
Simon O'Connor
Mechanisms of hypertension
211(1)
Epidemiological evidence for hypertension and its effects
212(2)
Definitions of hypertension
214(2)
Clinical presentations and investigations
216(1)
Target-organ effects of hypertension
216(2)
Blood vessels
216(1)
Cardiac effects
217(1)
Retinopathy
217(1)
Renal changes secondary to hypertension
218(1)
Brain
218(1)
Treatment and targets for hypertension control
218(1)
Specific targets linked to comorbid conditions
219(1)
Treatment for chronic primary hypertension
219(2)
Optimal or normal adult
219(1)
High-normal
220(1)
Stage 1 hypertension
220(1)
Higher stages of hypertension
220(1)
Treatment in an acute setting
221(2)
Self-assessment questions
223(2)
Chapter 9 Nephrology
225(36)
Annemarie Hennessy
Randall Faull
Inherited cystic kidney disease
226(3)
Autosomal dominant polycystic kidney disease (ADPCKD)
226(2)
Medullary sponge kidney (MSK)
228(1)
Medullary cystic disease and autosomal recessive polycystic disease
228(1)
Acquired kidney cystic disease
229(3)
Simple renal cysts
229(1)
Renal stones/kidney stones
229(3)
Kidney and urinary tract infection
232(1)
Mechanisms of disease
232(1)
Clinical presentation, investigation and diagnosis
232(1)
Treatment and targets for urinary tract infection
233(1)
Inherited renal basement membrane disease
233(1)
Thin basement membrane disease
233(1)
Alport syndrome
233(1)
Glomerulonephritis (GN)
233(9)
Classification
233(1)
Primary glomerular inflammatory disease
234(6)
Secondary glomerular inflammatory disease
240(2)
Sclerosing glomerular disease
242(2)
Diabetes mellitus
242(1)
Focal sclerosing glomerular nephropathy (FSGN)
243(1)
Vascular renal disease
244(1)
Renal artery stenosis
244(1)
Treatment of renovascular disease
245(1)
Thrombotic thrombocytopenic purpura OTP)/ Hemolytic uremic syndrome (HUS)
245(1)
Malignant hypertension
246(1)
Mechanisms of renal injury in hypertension
246(1)
Clinical presentation, investigation and diagnosis
246(1)
Treatment and targets
246(1)
Scleroderma kidney
247(1)
Mechanisms of scleroderma kidney and renal crisis
247(1)
Clinical presentation, investigation and diagnosis
247(1)
Treatment and targets for scleroderma
247(1)
Reflux nephropathy
247(1)
Clinical presentation, investigation and diagnosis
247(1)
Treatment and targets
248(1)
Chronic kidney disease (CKD)
248(4)
Classification systems and definitions
248(1)
Early stages of CKD
248(1)
Clinical presentations of stage 3 CKD
249(1)
Clinical presentations of stages 4 and 5 CKD
249(1)
End-stage renal disease (ESRD) and renal replacement therapy
249(3)
Acute renal failure--acute kidney injury (AKI)
252(1)
Tubulo-interstitial diseases
252(1)
Acute interstitial nephritis (AIN)
252(1)
Chronic tubulo-interstitial disease
253(1)
Electrolyte disorders
253(3)
Hypernatremia
253(1)
Hyponatremia
254(1)
Hyperkalemia
254(1)
Hypokalemia
255(1)
Inherited `channelopathies' associated with hypertension or HYPO/hyperkalemia
256(1)
Hypokalemic alkalosis (with and without hypertension)
256(1)
Renal tubular acidosis
256(1)
The kidneys in pregnancy and pregnancy-related diseases
257(2)
Normal adaptations to pregnancy
257(1)
Underlying renal disease
257(2)
Self-assessment questions
259(2)
Chapter 10 Endocrinology
261(56)
David Simmons
Rohit Rajagopal
Milan K Piya
Sue Lynn Lau
Mark Mclean
System overview
262(2)
Hormones, their transport and action
262(1)
Feedback control of hormone systems
262(1)
Evaluating function of hormone systems
263(1)
Pathogenic mechanisms of hormone disorders
263(1)
Disorders of the pituitary and hypothalamus
264(5)
Anatomy and physiology
264(1)
Pituitary mass lesions
265(1)
Hypopituitarism
266(1)
Syndromes of hypersecretion
267(1)
Surgery and radiotherapy for pituitary tumors
268(1)
Inflammatory and infiltrative disorders
268(1)
Diabetes insipidus (D1)
269(1)
Thyroid disorders
269(6)
Physiology and assessment of thyroid function
269(1)
Thyroid imaging
269(1)
Thyroid autoimmunity
270(1)
Hyperthyroidism
270(2)
Hypothyroidism
272(2)
Goiter and thyroid nodules
274(1)
Thyroid cancer
274(1)
Thyroid in pregnancy
275(1)
Disorders of bone and mineral metabolism
275(7)
Mineral homeostasis
275(1)
Hypercalcemia
275(3)
Hypocalcemia
278(1)
Osteoporosis
279(1)
Osteomalacia and rickets
280(1)
Vitamin D deficiency
280(1)
Paget's disease (PD)
281(1)
Adrenal disorders
282(7)
Physiology and assessment of adrenal function
282(1)
Adrenal insufficiency
282(2)
Cortisol excess (Cushing's syndrome)
284(1)
Primary hyperaldosteronism (Conn's syndrome)
285(1)
Pheochromocytoma
286(1)
Congenital adrenal hyperplasia (CAH)
287(2)
Incidentally found adrenal masses Cincidentaloma')
289(1)
Growth and puberty
289(3)
Causes of short stature
289(1)
Onset of puberty--physiology
289(1)
Causes of delayed puberty
290(1)
Common causes of precocious puberty
290(2)
Male reproductive endocrinology
292(1)
Testicular function
292(1)
Male hypogonadism
292(1)
Causes of erectile dysfunction
293(1)
Gynecomastia
293(1)
Androgen replacement therapy
293(1)
Female reproductive endocrinology
293(3)
Anatomy and physiology
293(1)
Clinical and laboratory evaluation
294(1)
Hirsutism and hyperandrogenism
295(1)
Polycystic ovary syndrome (PCOS)
295(1)
Female hypogonadism
295(1)
Endocrinology of pregnancy
296(1)
Neuroendocrine tumors (NETs)
296(2)
Overview
296(1)
Carcinoid syndrome
297(1)
Glucagonoma
297(1)
VIPoma
297(1)
Insulinoma
297(1)
Treatment of malignant NETS
298(1)
Disorders of multiple endocrine systems
298(1)
Multiple endocrine neoplasia (MEN)
298(1)
Other multiple endocrine tumor syndromes
299(1)
Polyglandular autoimmunity (PGA) syndromes
299(1)
Diabetes and metabolism
299(13)
Overview of energy metabolism
299(1)
Carbohydrate metabolism and diabetes
300(9)
Disorders of energy excess--overweight and obesity
309(2)
The metabolic syndrome
311(1)
Self-assessment questions
312(5)
Chapter 11 Gastroenterology
317(52)
Magnus Halland
Michael Potter
Georgia Edwards
Vimalan Ambikaipaker
Nicholas J Talley
Esophagus
318(3)
Dysphagia
318(1)
Motor disorders
318(2)
Esophagitis due to causes other than acid reflux
320(1)
Stomach
321(4)
Physiology of acid secretion
321(1)
Dyspepsia and its management
322(1)
Gastritis and gastropathy
323(1)
Peptic ulcer disease (PUD)
323(1)
Tumors
324(1)
Post-gastrectomy complications
324(1)
Gastroparesis
325(1)
Small bowel
325(11)
Celiac disease
325(1)
Diarrhea
326(7)
Malabsorption
333(1)
Microscopic colitis
334(1)
Tropical sprue
334(1)
Small intestinal bacterial overgrowth (SIBO)
335(1)
Eosinophilic gastroenteritis (EGE)
335(1)
Chronic idiopathic intestinal pseudoobstruction (CUP)
336(1)
Short bowel syndrome
336(1)
Nutritional deficiency
336(5)
Clinical clues to malnutrition
336(1)
Nutritional assessment in end-stage liver disease
336(4)
Enteral and parenteral nutrition
340(1)
Large bowel
341(9)
Irritable bowel syndrome (IBS)
341(1)
Constipation
341(2)
Diverticular disease
343(1)
Inflammatory bowel disease (IBD)
343(7)
Colon polyps
350(1)
Colon cancer screening
350(4)
Recommendations for screening and surveillance
350(2)
Fecal occult blood testing (FOBT)
352(1)
Malignant potential and surveillance
352(2)
Gastrointestinal bleeding
354(3)
Upper
354(1)
Lower
355(1)
Obscure Gl bleeding
356(1)
Management of iron-deficiency anemia
357(1)
Pancreas
357(5)
Acute pancreatitis
357(3)
Chronic pancreatitis
360(1)
Autoimmune pancreatitis (AIP)
361(1)
Pancreatic cysts
362(1)
Acknowledgments
362(1)
Self-assessment questions
363(6)
Chapter 12 Hepatology
369(36)
Robert Gibson
Magnus Halland
Nicholas J Talley
Liver function tests and their abnormalities
370(1)
Serum enzymes
370(1)
Tests of synthetic function
370(1)
Noninvasive hepatic fibrosis assessment
370(1)
Approach to the patient with liver disease
370(2)
Bilirubin metabolism and jaundice
372(3)
Viral hepatitis
375(6)
Hepatitis A (RNA virus)
375(1)
Hepatitis B (DNA virus)
376(3)
Hepatitis C (RNA virus)
379(1)
Hepatitis D, E and G
380(1)
Other viruses causing hepatitis
381(1)
Noninvasive assessment of liver fibrosis
381(1)
Cirrhosis
381(2)
Useful investigations
382(1)
Prognosis
382(1)
Management
382(1)
Ascites
383(2)
Management
383(2)
Hepatorenal syndrome (HRS)
385(1)
Management
386(1)
Hyponatremia
386(1)
Spontaneous bacterial peritonitis (SBP)
386(1)
Treatment
386(1)
Portal hypertensive bleeding
387(1)
Management
387(1)
Portosystemic encephalopathy (PSE)
388(2)
Precipitant-induced PSE
389(1)
Persistent PSE
389(1)
Minimal encephalopathy
389(1)
Portopulmonary hypertension (POPH)
390(1)
Hepatopulmonary syndrome (HPS)
390(1)
Cirrhotic cardiomyopathy
390(1)
Acute liver failure (ALF)
391(1)
Liver transplantation
391(1)
Drugs and the liver
392(2)
Acetaminophen (paracetamol) and acute liver disease
392(2)
Alcohol and the liver
394(1)
Specific liver diseases
394(3)
Budd-Chiari syndrome (BCS)
394(1)
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
395(1)
Wilson's disease (hepatolenticular degeneration)
396(1)
Alpha-1 anti-trypsin deficiency
396(1)
Hemochromatosis
396(1)
Autoimmune liver diseases
397(1)
Autoimmune hepatitis (AIH)
397(1)
Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)
397(1)
Systemic disease and the liver
398(1)
Pregnancy and liver disease
398(1)
Gallbladder and biliary tree
398(2)
Gallstones
399(1)
Acatcutous cholecystitis
400(1)
Porphyrias
400(1)
Acute intermittent porphyria (AIP)
400(1)
Porphyria cutanea tarda (PCT)
400(1)
Self-assessment questions
401(4)
Chapter 13 Hematology
405(52)
Stephen James Fuller
Hemostasis
406(2)
Essential concepts
406(1)
Components of the hemostatic system
406(2)
Venous thrombosis
408(2)
Predisposition to venous thrombosis
408(1)
Diagnosis of venous thrombosis
409(1)
Treatment of venous thromboembolism (VTE)
410(1)
Post-thrombotic syndrome (PTS)
410(1)
Antiphospholipid syndrome (APS)
410(1)
Treatment
411(1)
Thrombosis at unusual sites
411(1)
Cerebral vein thrombosis (CVT)
411(1)
Portal vein thrombosis (PVT)
411(1)
Cancer and thrombosis
411(1)
Bleeding disorders
412(3)
Von Willebrand disease (vWD)
412(2)
Hemophilia A
414(1)
Hemophilia B
415(1)
Bleeding disorders due to deficiencies of other coagulation factors
415(1)
Platelet disorders
415(2)
Idiopathic thrombocytopenic purpura (ITP)
415(1)
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
416(1)
Disseminated intravascular coagulation (DIC)
417(2)
Diagnosis
418(1)
Treatment
418(1)
Coagulopathy in intensive care patients
419(1)
Myeloproliferative disorders
419(5)
Polycythemia vera (PV)
419(2)
Essential thrombocythemia (ET)
421(2)
Primary myelofibrosis (PMF)
423(1)
Leukemia
424(8)
Acute myeloid leukemia (AMD
424(2)
Acute promyelocytic leukemia (APML)
426(1)
Acute lymphoblastic leukemia (ALL)
427(1)
Myelodysplastic syndrome (MDS)
427(1)
Chronic myeloid leukemia (CML)
428(2)
Chronic lymphocytic leukemia and other B-cell disorders
430(2)
Non-Hodgkin lymphomas
432(3)
Diagnosis
432(1)
Staging
432(1)
Diffuse large B-cell lymphoma (DLBCL)
432(1)
`Cell of origin' classification of DLBCL
433(1)
`Double-hit' (DH) and `triple-hit' (TH) lymphomas
433(1)
Burkitt lymphoma
433(1)
Follicular lymphoma (FL)
433(1)
Mantle cell lymphoma (MCL)
434(1)
Cutaneous lymphomas
434(1)
Hodgkin lymphoma (HL)
435(1)
Histological subtypes and cell biology
435(1)
Staging
435(1)
Risk stratification
435(1)
Plasma cell disorders
436(2)
Monoclonal gammopathy of uncertain significance (MGUS)
436(1)
Asymptomatic myeloma
436(1)
Symptomatic myeloma
436(1)
Prognostic markers in myeloma
437(1)
Treatment of myeloma
437(1)
Differential diagnosis
437(1)
Anemia
438(10)
Mechanisms of anemia
438(1)
Common laboratory tests used for diagnostic work-up
438(1)
Approach to iron-deficiency anemia
438(2)
Management of iron deficiency
440(1)
Anemia of chronic disease
440(1)
Thalassemias
440(1)
Sideroblastic anemias
441(1)
Macrocytic anemias
441(2)
Hemolytic anemias
443(5)
Drug-induced hemolysis
448(1)
Non-immune acquired hemolytic anemias (DAT negative)
448(1)
Acknowledgment
448(1)
Self-assessment questions
449(8)
Chapter 14 Oncology
457(36)
Victoria Bray
Wei Chua
Christos S Karapetis
Melissa Moore
What is cancer?
459(1)
DNA and genes
459(1)
Basic elements of cancer biology
459(1)
Essential elements of cancer diagnosis and treatment
459(1)
Prevention
459(1)
Diagnosis
460(1)
Screening
460(1)
Signs and symptoms
460(1)
Diagnostic tests
460(1)
Prognosis
461(1)
Cancer factors
461(1)
Patient factors
461(1)
Prognostic vs predictive factors
461(1)
Treatment principles
461(1)
Defining treatment goals
461(1)
Adjuvant therapy
462(1)
Neoadjuvant therapy
462(1)
Supportive management
462(1)
Maintenance therapy
462(1)
Principles of chemotherapy
462(1)
Attitudes to chemotherapy
463(1)
Toxicity of cytotoxic chemotherapy
463(1)
Principles of radiotherapy
463(1)
Fractionation
464(1)
Radiation effects
464(1)
Treatment responsiveness
464(1)
Endocrine responsive
464(1)
Potentially curable following chemotherapy alone
464(1)
Tumors very sensitive to chemotherapy
464(1)
Potentially curable following radiotherapy
464(1)
Personalized medicine
464(1)
Molecular targeted therapy
464(1)
Monoclonal antibodies (the ABs')
464(1)
Tyrosine kinase inhibitors (the `IBs')
465(1)
Other
465(1)
Familial cancers and cancer genetics
465(1)
Oncological emergencies
465(2)
Spinal cord compression
465(1)
Febrile neutropenia
466(1)
Cardiac tamponade
466(1)
Addisonian crisis
467(1)
Disseminated intravascular coagulation (DIC)
467(1)
Hypercalcemia
467(1)
Hyponatremia
467(1)
Superior vena cava (SVC) obstruction
467(1)
Raised intracranial pressure (ICP)
467(1)
Tumor markers in serum
467(1)
Paraneoplastic syndrome
468(1)
Cancer with unknown primary (CUP)
468(1)
Diagnosis
468(1)
Potentially treatable subgroups of CUP
468(1)
Recent research and future directions
469(1)
Lung cancer
469(2)
Clinical presentation
469(1)
Risk factors
469(1)
Epidemiology and pathology
469(1)
Non-small-cell lung cancer (NSCLC)
469(1)
Molecular profiling
469(1)
Prognosis
469(1)
Management
469(1)
Treatment of stage IV NSCLC
470(1)
Small cell lung cancer (SCLC)
471(1)
Renal cancer
471(1)
Background
471(1)
Diagnosis and staging
471(1)
Treatment
472(1)
Prognosis
472(1)
Tumors of the pelvis, ureter and bladder
472(1)
Epidemiology
472(1)
Risk factors
472(1)
Clinical presentation
473(1)
Investigation and diagnosis
473(1)
Treatment
473(1)
Prostate cancer
473(1)
Epidemiology
473(1)
Screening
473(1)
Staging
473(1)
Management
473(1)
Testis cancer
474(2)
Epidemiology and risk
474(1)
Pathology
474(1)
Diagnosis
474(1)
Prognostic factors in stage I NSGCT
475(1)
Treatment
475(1)
Post-chemotherapy residual masses
475(1)
Relapsed disease
476(1)
High-dose chemotherapy (HDCT)
476(1)
Head and neck cancer
476(1)
Early-stage disease
476(1)
Advanced-stage disease
476(1)
Human papillomavirus (HPV) infection
476(1)
Esophageal cancer
476(1)
Pathology and epidemiology
476(1)
Clinical presentation
476(1)
Diagnosis and screening
477(1)
Management
477(1)
Gastric cancer
477(1)
Epidemiology
477(1)
Clinical presentation
477(1)
Diagnosis
477(1)
Treatment
477(1)
Gastric MALT lymphoma
478(1)
Colorectal cancer
478(2)
Pathology and epidemiology
478(1)
Diagnosis and staging
478(1)
Management
479(1)
Future directions
480(1)
Pancreatic cancer
480(1)
Key points
480(1)
Epidemiology
480(1)
Diagnosis
480(1)
Management
480(1)
Hepatocellular carcinoma (HCC)
481(1)
Key points
481(1)
Risk factors
481(1)
Prognosis
481(1)
Treatment
481(1)
Brain tumors
482(1)
Low-grade glioma (astrocytoma and oligodendroglioma)
482(1)
Glioblastoma multiforme (GBM)
482(1)
Lymphoma
482(1)
Melanoma
483(1)
Pathology and epidemiology
483(1)
Diagnosis and staging
483(1)
Management
483(1)
Advanced disease
483(1)
Non-melanoma skin cancer
483(1)
Risk factors
483(1)
Management
484(1)
Sarcoma
484(1)
Clinical presentation
484(1)
Diagnosis
484(1)
Treatment
484(1)
Breast cancer
485(2)
Epidemiology
485(1)
Risk factors
485(1)
Pathology
485(1)
Screening
485(1)
Diagnosis and staging
485(1)
Management
485(2)
Recent research and future directions
487(1)
Ovarian cancer
487(1)
Key points
487(1)
Pathology and epidemiology
487(1)
Diagnosis
488(1)
Management
488(1)
Future directions
488(1)
Endometrial cancer
488(1)
Pathology and epidemiology
488(1)
Diagnosis
488(1)
Management
489(1)
Cancer survivorship
489(1)
Self-assessment questions
490(3)
Chapter 15 Palliative Medicine
493(14)
Meera Agar
Katherine Clark
David Currow
Pain
494(2)
Definition
494(1)
Impact of the problem
494(1)
Pathophysiological basis
494(1)
Interventions to palliate the problem
494(2)
Mucositis
496(1)
Definition
496(1)
Impact of the problem
496(1)
Pathophysiological basis
496(1)
Interventions
496(1)
Fatigue
497(1)
Definition
497(1)
Impact of the problem
497(1)
Pathophysiological basis
497(1)
Interventions to palliate the problem
497(1)
Nausea and vomiting
497(3)
Definition
497(1)
Impact of the problem
498(1)
Pathophysiological basis
498(1)
Interventions to palliate the problem
498(2)
Cachexia and anorexia
500(1)
Definition
500(1)
Impact of the problems
500(1)
Underlying pathophysiological basis
500(1)
Interventions
501(1)
Breathlessness
501(1)
Definition
501(1)
Impact of the problem
501(1)
Pathophysiological basis
501(1)
Interventions to palliate the problem
502(1)
Constipation
502(1)
Definition
502(1)
Impact of the problem
502(1)
Pathophysiological basis
502(1)
Interventions to palliate the problem
502(1)
Delirium
502(1)
Definition
502(1)
Impact of the problem
502(1)
Pathophysiological basis
503(1)
Interventions to palliate the problem
503(1)
Insomnia
503(2)
Definition
503(1)
Impact of the problem
503(1)
Pathophysiological basis
503(1)
Interventions to palliate the problem
504(1)
Self-assessment questions
505(2)
Chapter 16 Immunology
507(56)
Brad Frankum
Monique Wei Meng Lee
Jessie A Lee
Key concepts in immunobiology
508(5)
Innate and adaptive immunity
508(1)
Specificity and diversity
509(1)
Immunological memory
510(1)
Hypersensitivity, autoimmunity and immunodeficiency
511(1)
Immunity, inflammation and tissue repair
511(1)
Understanding immunobiology
512(1)
Manipulation of the immune system
512(1)
Allergic disease
513(13)
Anaphylaxis
513(1)
Allergic rhinitis (AR) and allergic conjunctivitis (AC)
514(2)
Chronic rhinosinusitis
516(2)
Atopic dermatitis (AD)
518(1)
Food allergy
519(2)
Urticaria and angioedema
521(3)
Drug allergy
524(1)
Insect venom allergy
525(1)
Eosinophilia
526(1)
Hypereosinophilic syndrome (HES)
526(1)
Mast cell disorders
527(1)
Cutaneous mastocytosis (CM)
527(1)
Systemic mastocytosis (SM)
527(1)
Systemic autoimmune disease
528(12)
Systemic lupus erythematosus (SLE)
528(4)
Sjogren's syndrome (SS)
532(3)
Inflammatory myopathies
535(1)
Anti-synthetase syndrome
535(2)
Scleroderma and CREST syndrome
537(1)
Mixed connective tissue disease (MCTD)
538(1)
Antiphospholipid syndrome (APS)
539(1)
IgG4-related disease
539(1)
Primary vasculitis
540(6)
Large-vessel vasculitis
540(2)
Medium-vessel vasculitis
542(1)
Small-vessel vasculitis
543(2)
Single-organ vasculitis
545(1)
Variable-vessel vasculitis
545(1)
Autoinflammatory disorders
546(1)
Familial Mediterranean fever (FMF)
546(1)
TNF-receptor-associated periodic syndrome (TRAPS)
547(1)
Immunodeficiency
547(3)
Primary immunodeficiency
547(3)
Secondary (acquired) immunodeficiency
550(1)
HIV/AIDS
550(7)
Epidemiology
551(1)
Risk factors for HIV infection
551(1)
Pathophysiology
551(1)
Clinical features and diagnosis
552(1)
Management
553(2)
Prognosis
555(2)
Self-assessment questions
557(6)
Chapter 17 Musculoskeletal Medicine
563(36)
Carlos El Haddad
Kevin Pile
An approach to a patient with painful joints
564(2)
History
564(1)
Examination
565(1)
Investigations
566(1)
Rheumatoid arthritis (RA)
566(5)
Genetics and environmental contribution to RA
566(1)
Pathology
567(1)
Diagnosis
567(1)
Clinical features and complications
567(2)
Investigations
569(1)
Treatment
569(2)
Conclusions
571(1)
Spondyloarthropathies
571(4)
Ankylosing spondylitis (AS)
572(1)
Psoriatic arthritis (PsA)
573(1)
Reactive arthritis (ReA)
574(1)
IBD-associated spondyloarthropathy
575(1)
Adult-onset Still's disease (AOSD)
575(1)
Crystal arthropathies
575(5)
Gout
575(4)
Pseudogout
579(1)
Relapsing polychondritis (RP)
580(1)
Osteoarthritis (OA)
580(4)
Types of osteoarthritis
581(1)
Clinical features
581(1)
Specific joint involvement
581(1)
Investigations
582(1)
Treatment
582(2)
Genetic connective tissue disorders
584(1)
Painful shoulders
584(3)
Clinical assessment
585(1)
Examination
585(1)
Rotator cuff disease
585(1)
Frozen shoulder/adhesive capsulitis
586(1)
Tennis elbow and golfer's elbow
587(1)
Tennis elbow (lateral epicondylitis)
587(1)
Golfer's elbow (medial epicondylitis)
587(1)
Plantar fasciitis
588(1)
Fibromyalgia
588(2)
Epidemiology and etiology
589(1)
Investigations
589(1)
Prognosis, differential diagnosis and treatment
590(1)
Septic arthritis
590(1)
Investigations
591(1)
Treatment
591(1)
Acute low back pain
591(3)
Specific pathology leading to acute low back pain
592(1)
Management
593(1)
Outcome
593(1)
Chronic low back pain
594(1)
Clinical assessment
594(1)
Conservative treatment
594(1)
Invasive treatment
594(1)
Self-assessment questions
595(4)
Chapter 18 Neurology
599(58)
Christopher Levi
Thomas Wellings
Disorders of consciousness
600(2)
Definitions
600(1)
Levels of consciousness
600(1)
Causes of coma
600(1)
Assessment of the patient with impaired consciousness
601(1)
Headache
602(6)
Primary headache syndromes
602(4)
Secondary headache
606(2)
Stroke
608(4)
Acute assessment and management
608(1)
Thrombolysis
609(1)
Neurosurgical intervention
610(1)
General care measures
611(1)
Early secondary prevention
611(1)
Intracerebral hemorrhage
612(1)
Medical treatment
612(1)
Surgical management
612(1)
Subarachnoid hemorrhage (SAH)
612(1)
Natural history and outcome of an aneurysmal SAH
612(1)
Surgical versus endovascular management of SAH
612(1)
Transient ischemic attack (TIA)
613(1)
Definition
613(1)
Differential diagnosis of transient neurological disturbances
613(1)
Pathophysiology
613(1)
Investigation
613(1)
Recurrent event risk
613(1)
Prevention of recurrent events
613(1)
Dementia
614(3)
Diagnosis
614(1)
Major dementia syndromes
614(1)
Diagnostic work-up of the dementia patient
615(1)
Other dementia syndromes
615(2)
Seizures and the epilepsies
617(7)
Seizure types
617(1)
Assessing a patient after a seizure
618(1)
Investigation of a first seizure
619(1)
The epilepsies
619(1)
Important epilepsy syndromes
619(3)
Choice of anticonvulsant therapy
622(1)
Status epilepticus
622(2)
Non-epileptic seizures
624(1)
Balance, dizziness and vertigo
624(5)
Hemodynamic dizziness or `lightheadedness'
625(1)
Vertigo
625(2)
Central pathologies
627(1)
Treatment of vertiginous patients
628(1)
Other balance disorders
629(1)
Movement disorders
629(7)
Tremor
629(1)
Parkinson's disease (PD)
630(3)
Dementia with Lewy bodies (DLB)
633(1)
Multisystem atrophy (MSA)
633(1)
Progressive supranuclear palsy (PSP)
633(1)
Corticobasat syndrome
633(1)
Dystonia
633(1)
Hyperkinetic movement disorders
634(1)
NMDA encephalitis
635(1)
Multiple sclerosis and CNS inflammation
636(5)
Multiple sclerosis (MS)
636(4)
Neuromyelitis optica (NMO; `Devic's disease')
640(1)
Acute disseminated encephalomyelitis (ADEM) and transverse myelitis (TM)
640(1)
Neurological manifestations of sarcoidosis and Behcet's disease
641(1)
Sarcoidosis
641(1)
Behget's disease
641(1)
Neuromuscular disease
641(4)
Myopathy
642(2)
Genetic disorders
644(1)
Neuromuscular disorders
645(7)
Myasthenia gravis (MG)
645(2)
Disorders of peripheral nerves
647(1)
Motor neuron disease (MND)/amyotrophic lateral sclerosis
647(2)
Demyelinating neuropathy and Guillain-Barre syndrome (GBS)
649(1)
Peripheral neuropathy
650(2)
Self-assessment questions
652(5)
Chapter 19 Psychiatry For The Internist
657(10)
Brian Kelly
Lisa Lampe
Depression
657(1)
Anxiety disorders
658(1)
Treatment
659(1)
Post-traumatic stress disorder (PTSD)
659(1)
Somatization
659(1)
Eating disorders
660(1)
Anorexia and bulimia nervosa
661(1)
Suicide and deliberate self-harm
661(1)
Psychotropic agents
662(3)
Lithium carbonate
662(1)
Anticonvulsants
662(1)
Antipsychotic agents
663(1)
Antidepressants
664(1)
Self-assessment questions
665(2)
Chapter 20 Clinical Infectious Diseases
667(44)
Iain Gosbell
D Ashley R Watson
Clinical approach to infectious diseases
668(1)
Overview
668(1)
History
668(1)
Examination
668(1)
Diagnostics in infectious diseases
669(1)
Pre-analytical considerations
669(1)
Analytical considerations
669(1)
Post-analytical considerations
669(1)
Selected common clinically important organisms
670(7)
Selected bacteria
670(2)
Selected viruses
672(2)
Selected fungi
674(3)
Selected parasites
677(1)
Anti-infective treatment
677(3)
Is infection likely?
677(1)
What are the likely pathogen(s)?
678(1)
Are anti-infective drugs required?
679(1)
Choice of empirical and definitive antibiotics
679(1)
What host factors need consideration?
679(1)
What therapy other than antibiotics is required?
679(1)
Ongoing assessment and further results
679(1)
What is the duration and endpoint of treatment?
679(1)
Anti-infective agents
680(10)
Antibiotics
680(7)
Antiviral agents
687(1)
Antifungals
688(2)
Specific syndromes
690(5)
Acute fever
690(1)
Pyrexia of unknown origin (PUO)
690(2)
Skin and soft tissue infections
692(2)
Drug fever
694(1)
Infections in special hosts and populations
695(7)
Infections in immunosuppressed patients
695(1)
Sexually transmitted infections (STIs)
696(6)
Systemic viral infections
702(4)
HIV
702(1)
Hepatitis viruses
702(1)
Herpesviruses
702(1)
Zoonoses
703(3)
Infection prevention and control
706(2)
Administrative support
706(1)
Judicious use of antibiotics
707(1)
MRO surveillance
707(1)
Infection control precautions
707(1)
Environmental measures
707(1)
Decolonization
707(1)
Self-assessment questions
708(3)
Chapter 21 Immunization
711(16)
Robert W Pickles
General principles
711(1)
Immunizing agents
712(2)
Factors affecting immunogenicity
714(1)
Chemical and physical properties of antigens (vaccines)
714(1)
Physiological attributes of individuals
714(1)
Route of administration
714(1)
Presence of adjuvants
714(1)
Contraindications
714(1)
False contraindications
714(1)
Egg allergy
714(1)
Booster doses
714(1)
Immunization in specific populations
714(5)
Pregnancy
714(1)
Preconception
715(1)
Breastfeeding
715(1)
Immunocompromised hosts
715(4)
Oncology patients
719(1)
Solid-organ transplant patients
719(1)
Hemopoetic stem-cell transplant (HSCT) recipients
719(1)
HIV/AIDS
719(1)
Asplenia
719(1)
Occupational exposure
719(1)
Travel vaccines
719(1)
Post-exposure prophylaxis (PEP)
719(2)
Intramuscular immune globulin
719(1)
Specific intramuscular immune globulin preparations (hyperimmune globulins)
719(2)
Specific immune globulins for intravenous use
721(1)
Routine immunization of adults
721(1)
Self-assessment questions
722(5)
Chapter 22 Dermatology For The Physician
727(12)
Brad Frankum
Saxon D Smith
Autoinflammatory diseases of the skin
727(5)
Acne
727(1)
Atopic dermatitis
728(1)
Hidradenitis suppurativa
728(1)
Psoriasis
729(1)
Erythema nodosum (EN)
729(1)
Bullous lesions
730(1)
Dermatitis herpetiformis
731(1)
Livedo reticularis
732(1)
Skin problems associated with underlying systemic disease
732(3)
Acanthosis nigricans
732(1)
Neutrophilic dermatoses
733(1)
Pruritus
734(1)
Pigmentation
734(1)
Photosensitivity
734(1)
Rash on the palms and soles
734(1)
Red person syndrome (erythroderma or exfoliative dermatitis)
734(1)
Excessive sweating (hyperhydrosis)
735(1)
Facial flushing
735(1)
Genetic or congenital skin diseases
735(1)
The phakomatoses
735(1)
Skin disease associated with malignancy
736(2)
Primary or secondary malignancy
736(1)
Underlying malignancy
737(1)
Self-assessment questions
738(1)
Chapter 23 Medical Ophthalmology
739(16)
Michael Hennessy
Brad Frankum
Peter Mccluskey
Elisa Cornish
Introduction
739(1)
Ocular history
740(1)
Ocular examination
740(4)
General inspection findings
740(1)
Visual acuity
740(1)
Intraocular pressure
740(1)
Field of vision
741(1)
Pupils
741(1)
Color saturation
742(1)
Ocular motility
742(1)
Ophthalmoscopy
743(1)
Auscultation
743(1)
Ocular conditions
744(3)
Retinal vascular disease
744(1)
Retinal arterial occlusion
744(1)
Retinal venous occlusion
745(1)
Diabetic retinopathy (DR)
746(1)
Uveitis
747(1)
Scleritis
747(1)
Thyroid-related orbitopathy
747(1)
Dry eye
748(1)
Neoplasia and the eye
748(1)
Neuro-ophthalmology
749(1)
Optic neuritis (ON)
749(1)
Non-arteritic anterior ischemic optic neuropathy (NAION)
749(1)
Arteritic anterior ischemic optic neuropathy (AAION)
749(1)
Papilledema
750(1)
Extraocular muscle paralysis
750(1)
Phakomatoses
750(1)
Ocular effects of systemic medication
750(2)
Self-assessment questions
752(3)
Chapter 24 Women's Health for the Physician
755(16)
Steve Robson
Andrew Korda
Infertility
755(2)
Age and infertility
756(1)
Anovulatory infertility
756(1)
Hyperprolactinemia
757(1)
Infertility due to anatomical abnormalities of the reproductive tract
757(1)
Male factor infertility
757(1)
Unexplained infertility
757(1)
Contraception
757(3)
Steroidal contraception
758(2)
Emergency contraception
760(1)
Menopausal symptoms
760(1)
Premenstrual syndrome
761(1)
Abnormal uterine bleeding
761(1)
Diagnosis
761(1)
Management
762(1)
Dysmenorrhea
762(1)
Vulvar conditions
762(3)
Management
762(1)
Conditions with abnormalities on examination
763(2)
Sexually transmitted infections (STIs)
765(1)
Chlamydia
765(1)
Gonorrhea
766(1)
Pelvic inflammatory disease (PID)
766(1)
Ctinical features
766(1)
Treatment
767(1)
Sexual problems
767(2)
Treatment
768(1)
Self-assessment questions
769(2)
Chapter 25 Obstetric Medicine
771(18)
Annemarie Hennessy
Angela Makris
General principles of medical obstetric care
772(1)
Diabetes in pregnancy
772(3)
Gestational diabetes
773(1)
Type 1 Diabetes in pregnancy
774(1)
Type 2 Diabetes in pregnancy
774(1)
Hypertension in pregnancy
775(2)
Mechanisms of disease
775(1)
Clinical presentation, investigation and diagnosis
775(1)
Treatment and targets
776(1)
Prevention strategies for preeclampsia
776(1)
Respiratory disease in pregnancy
777(1)
Pneumonia
777(1)
Asthma
777(1)
Venous thromboembolism (VTE) in pregnancy
778(1)
Thyroid disorders in pregnancy
778(1)
Hypothyroidism
779(1)
Hyperthyroidism
779(1)
Common gastroenterological and liver disorders in pregnancy
779(2)
Gastroesophageal reflux disease (GERD)
779(1)
Constipation and irritable bowel syndrome (IBS)
779(1)
Inflammatory bowel disease (IBD)
780(1)
Cholestasis of pregnancy
780(1)
Acute fatty liver of pregnancy (AFLP)
781(1)
Budd-Chiari syndrome in pregnancy
781(1)
Viral infection in pregnancy
781(1)
Viral hepatitis
781(1)
Immunological and hematological disease in pregnancy
782(1)
Systemic lupus erythematosus (SLE)
782(1)
Antiphospholipid syndrome (APS)
782(1)
Idiopathic thrombocytopenic purpura (ITP)
783(1)
Iron-deficiency anemia (IDA)
783(1)
Cardiac disease in pregnancy
783(2)
Valvular heart disease
783(1)
Arrhythmias and palpitations
784(1)
Cardiomyopathy, including postpartum cardiomyopathy
784(1)
Other vascular conditions
784(1)
Obesity in pregnancy
785(1)
Neurological conditions in pregnancy
785(1)
Self-assessment questions
786(3)
Chapter 26 Geriatric Medicine
789(18)
Will Browne
Balakrishnan Kichu R Nair
Elizabeth Whiting
Jeffrey Rowland
Paven Preet Kaur
Ramdeep Bajwa
Introduction
790(1)
Epidemiology of aging
790(1)
Theories of aging
790(1)
Processes underlying aging
790(1)
Homeostenosis
790(1)
Evolution and aging
790(1)
Telomere shortening and mitochondrial dysfunction
790(1)
Endocrine factors associated with aging
790(1)
Inflammation and aging
791(1)
Free radicals and aging
791(1)
Programmed aging
791(1)
Physiology of aging
791(1)
Cardiovascular changes
791(1)
Cardiac changes
791(1)
Renal changes
791(1)
Musculoskeletal changes
791(1)
Neurological changes
792(1)
Skin changes
792(1)
Metabolic and endocrine changes
792(1)
Gastrointestinal changes
792(1)
Pathology: disease in older people
792(4)
Concepts related to aging
792(1)
Common problems typical to older people
793(3)
Atypical presentation of acute illness
796(1)
Delirium
796(1)
Declining mobility and falls
796(1)
New incontinence
796(1)
Geriatrics, the 5M's and the role of the Geriatrician
797(1)
Approach to comprehensive geriatric assessment
797(1)
Special considerations
798(1)
Undernutrition
798(1)
Advance care planning
798(1)
Capacity
798(1)
End of life care
799(1)
Immunizations
799(1)
Elder abuse
799(1)
Treatment considerations
799(1)
Polypharmacy
799(1)
Bed rest
799(1)
Futility of treatment
799(1)
Self-assessment questions
800(7)
Index 807